Search
Close this search box.
Search

Women's Health

Horizon

The Horizon test by Natera is a genetic test designed for carrier screening, which identifies whether a person carries genetic mutations that can be passed on to their children and result in recessive genetic diseases. It is especially useful for couples planning to conceive, helping to identify risks of transmitting hereditary conditions.

Overview

88% of carriers of Cystic Fibrosis, Spinal Muscular Atrophy (SMA), and Fragile X Syndrome have no family history.

Source: 1Archibald et al. Genet Med. 2018;20:513-523.

1 in 7 people are carriers of recessive diseases.

Source: Westemeyer et al. Genet Med. 2020;22(8):1320-28.

1 in 634 babies are affected by at least one of the conditions tested in the Horizon panel.

Source: Westemeyer et al. Genet Med. 2020;22(8):1320-28.

When Should You Consider This Test?

Consider this test in the following cases:

Couples planning to have children
To identify if both are carriers of mutations in the same gene, increasing the risk of a genetic disease in their children.
Family history
People with a family history of genetic diseases can benefit from the test to assess their risks.
Current pregnancy
Pregnant women can take the test to identify the risk of the baby inheriting genetic conditions.
Donors
Sperm donors or Egg donors.

Genes Analyzed

The panel includes:

2 up to 613

Genes

See the documents section for the list of conditions and tested genes

Methodology

The methodology used for this test is as follows:

PREPARATION:

Blood: No fasting required.

Saliva: 30 minutes of fasting.

TURNAROUND TIME:

Up to 20 calendar days.

REQUIRED DOCUMENTS:

Medical request.

Sample:

Blood
Saliva
TypeDescription
TechniqueNext-Generation Sequencing (NGS)
Accuracy99%

How to Request the Test?

Auxiliary Documents

Horizon Condition List
Contact Our Customer Services
Exatus Gene will send a collection kit and provide instructions for sample collection
We will retrieve the collected sample and send it to the laboratory for analysis
The report will be made available through the SysGene Portal and sent to your email.